Quebec Man Files $200 Million Lawsuit Against Manufacturers of Withdrawn Antidepressant

TORONTO - A Quebec man filed a $200 million class action lawsuit against Bristol-Myers Squibb (BMS) and all other companies that manufactured generic versions of Serzone claiming that his use of the antidepressant caused him to suffer liver failure. Steven Ledyit, et al., v. Bristol-Myers Squibb Canada Inc., et al., No. 03-CV-257695CP (Ontario Super. Ct.).

Plaintiff Steve Ledyit filed the suit in Ontario's Superior Court of Justice the day after Health Canada publicly announced that the sales of Serzone, known generically as nefazodone hydrochloride (NH), would be discontinued after Nov. 27 due to rising concerns about the drug's association with …